IQ LASER VISION, A LEADER IN EYE CARE IN THE LOS ANGELES AREA, IS PROUD TO ANNOUNCE FDA APPROVAL FOR PERMANENT LENS IMPLANTS THAT TREAT NEARSIGHTEDNESS AND ASTIGMATISM LOS ANGELES, June 08, 2022 (GLOBE NEWSWIRE) -- IQ Laser Vision, an ophthalmology practice with experienced eye physicians offering state-of-the-art services, is proud to announce a new vision...

Evo Visian® ICL Launches in the U.S.; an Evolutionary Vision Correction Procedure to Treat Nearsightedness is Now Available at Coastal Vision Medical Group CHINO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- EVO Visian® ICL ("EVO") is an evolutionary, clinically-proven implantable lens that corrects common vision problems such as nearsightedness and...

EVO ICL UNITED STATES LAUNCH: First group of patients race to Parkhurst Nuvision in San Antonio for new LASIK Eye Surgery Alternative San Antonio, Texas , April 05, 2022 (GLOBE NEWSWIRE) -- With the recent FDA approval of EVO Visian® ICL (referred to as “EVO”), patients are lining up to get the new vision procedure now available...

EVO VISIAN® ICL NOW AVAILABLE IN THE US: PARKHURST NUVISION OF SAN ANTONIO TEXAS AMONG FIRST IN THE UNITED STATES TO OFFER THIS EVOLUTIONARY VISION CORRECTION PROCEDURE San Antonio, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- EVO Visian® ICL (referred to as “EVO”) is an evolutionary innovation in vision correction surgery. EVO ICL is an implantable lens placed just...